Explore the intersection of regulation and innovation in healthcare through a panel discussion featuring experts from Innovative Medicines Initiative, Johns Hopkins Medical Institute, Nanyang Technological University, Novartis, and the University of Oxford. Delve into topics such as genetics, digital health, clinical trials, and strategies for regulatory change. Examine areas most in need of innovation, including medical education, and identify barriers to progress such as regulation, incentives, and data sharing. Consider the role of rare disease groups, trust, and self-regulation in shaping the future of healthcare. Gain insights on controversial topics like designer babies and reflect on the panelists' final thoughts on balancing innovation with responsible regulation in the health sector.